Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapy

Parkinsonism and Related Disorders

Volumn 13, Issue 8, 2007, Pages 495-499

  Dahodwala, N ^a,b   Connolly, J ^a   Farmer, J ^a   Stern, M B ^a   Jennings, D ^c   Siderowf, A ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

Author keywords

Genetics; Interest; Parkinson's disease; Preclinical; Predictive testing

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; MALE; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGED; ANALYSIS OF VARIANCE; ELECTRONIC MAIL; FAMILY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 36048976612     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.02.010     Document Type: Article

References (19)

1. McInerney-Leo A., Hadley D.W., Gwinn-Hardy K., and Hardy J. Genetic testing in PD. Mov Disord 20 1 (2005) 1-10
2. Piccini P., Burn D.J., Ceravolo R., Maraganore D., and Brooks D.J. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45 5 (1999) 577-582
3. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E.ch., and Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56 2 (2004) 175-181
4. 123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 57 (2001) 2089-2094
5. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
6. Schwartz L.M., Woloshin S., Fowler F.J., and Welch H.G. Enthusiasm for cancer screening in the United States. JAMA 291 1 (2004) 71-77
7. Roberts J.S. Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. Gerontology 40 1 (2000) 43-52
8. Markel J.S., Young A.B., and Penney J.B. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am J Med Genet 26 (1987) 295-305
9. Kessler S., Field T., Worth L., and Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet 26 (1987) 259-270
10. Mastromauro C., Myers R.H., and Berkman B. Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 26 (1987) 271-282
11. Meissen G.J., and Berchek R.L. Intended use of predictive testing by those at risk for Huntington disease. Am J Med Genet 26 (1987) 283-293
12. Stern R., and Eldridge R. Attitudes of patients and their relatives to Huntington's disease. J Med Genet 12 (1975) 217-223
13. McCrae C.A., Deim G., Yamazaki T.G., Mitek A., and Wszolek Z.K. Interest in genetic testing in pallido-ponto-nigral degeneration (PPND): a family with frontotemporal dementia with Parkinsonism linked to chromosome 17. Eur J Neurol 8 (2001) 179-183
14. Quaid K.A., Brandt J., and Folstein S.E. The decision to be tested for Huntington's disease. JAMA 257 24 (1987) 3362
15. Crauford D., Dodge A., Kerzin-Storrer L., and Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 2 (1989) 603-605
16. Quaid K.A., and Morris M. Reluctance to undergo predictive testing: the case of Huntington's disease. Am J Med Genet 45 (1993) 41-45
17. McKinnon W.C., Baty B.J., Bennett R.L., Magee M., Neufeld-Kaiser W.A., and Peters K.F. Predisposition genetic testing for late-onset disorders in adults: a position paper of the National Society of Genetic Counselors. JAMA 278 15 (1997) 1217-1219
18. Jacobs H., Latza U., Vieregge A., and Vieregge P. Attitudes of young patients with Parkinson's disease towards possible presymptomatic testing and prenatal genetic testing. Genet Couns 12 1 (2001) 55-67
19. Binedell J., Soldan J.R., and Harper P.S. Predictive testing for Huntington's disease: I. Predictors of uptake in South Wales. Clin Genet 54 (1998) 477-488